1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genetically Modified Drug Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Genetically Modified Drug by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Genetically Modified Drug by Country/Region, 2018, 2022 & 2029
2.2 Genetically Modified Drug Segment by Type
2.2.1 Transgenic Animal
2.2.2 Transgenic Plant
2.3 Genetically Modified Drug Sales by Type
2.3.1 Global Genetically Modified Drug Sales Market Share by Type (2018-2023)
2.3.2 Global Genetically Modified Drug Revenue and Market Share by Type (2018-2023)
2.3.3 Global Genetically Modified Drug Sale Price by Type (2018-2023)
2.4 Genetically Modified Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Genetically Modified Drug Sales by Application
2.5.1 Global Genetically Modified Drug Sale Market Share by Application (2018-2023)
2.5.2 Global Genetically Modified Drug Revenue and Market Share by Application (2018-2023)
2.5.3 Global Genetically Modified Drug Sale Price by Application (2018-2023)
3 Global Genetically Modified Drug by Company
3.1 Global Genetically Modified Drug Breakdown Data by Company
3.1.1 Global Genetically Modified Drug Annual Sales by Company (2018-2023)
3.1.2 Global Genetically Modified Drug Sales Market Share by Company (2018-2023)
3.2 Global Genetically Modified Drug Annual Revenue by Company (2018-2023)
3.2.1 Global Genetically Modified Drug Revenue by Company (2018-2023)
3.2.2 Global Genetically Modified Drug Revenue Market Share by Company (2018-2023)
3.3 Global Genetically Modified Drug Sale Price by Company
3.4 Key Manufacturers Genetically Modified Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Genetically Modified Drug Product Location Distribution
3.4.2 Players Genetically Modified Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Genetically Modified Drug by Geographic Region
4.1 World Historic Genetically Modified Drug Market Size by Geographic Region (2018-2023)
4.1.1 Global Genetically Modified Drug Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Genetically Modified Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Genetically Modified Drug Market Size by Country/Region (2018-2023)
4.2.1 Global Genetically Modified Drug Annual Sales by Country/Region (2018-2023)
4.2.2 Global Genetically Modified Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Genetically Modified Drug Sales Growth
4.4 APAC Genetically Modified Drug Sales Growth
4.5 Europe Genetically Modified Drug Sales Growth
4.6 Middle East & Africa Genetically Modified Drug Sales Growth
5 Americas
5.1 Americas Genetically Modified Drug Sales by Country
5.1.1 Americas Genetically Modified Drug Sales by Country (2018-2023)
5.1.2 Americas Genetically Modified Drug Revenue by Country (2018-2023)
5.2 Americas Genetically Modified Drug Sales by Type
5.3 Americas Genetically Modified Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genetically Modified Drug Sales by Region
6.1.1 APAC Genetically Modified Drug Sales by Region (2018-2023)
6.1.2 APAC Genetically Modified Drug Revenue by Region (2018-2023)
6.2 APAC Genetically Modified Drug Sales by Type
6.3 APAC Genetically Modified Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Genetically Modified Drug by Country
7.1.1 Europe Genetically Modified Drug Sales by Country (2018-2023)
7.1.2 Europe Genetically Modified Drug Revenue by Country (2018-2023)
7.2 Europe Genetically Modified Drug Sales by Type
7.3 Europe Genetically Modified Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genetically Modified Drug by Country
8.1.1 Middle East & Africa Genetically Modified Drug Sales by Country (2018-2023)
8.1.2 Middle East & Africa Genetically Modified Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Genetically Modified Drug Sales by Type
8.3 Middle East & Africa Genetically Modified Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Genetically Modified Drug
10.3 Manufacturing Process Analysis of Genetically Modified Drug
10.4 Industry Chain Structure of Genetically Modified Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Genetically Modified Drug Distributors
11.3 Genetically Modified Drug Customer
12 World Forecast Review for Genetically Modified Drug by Geographic Region
12.1 Global Genetically Modified Drug Market Size Forecast by Region
12.1.1 Global Genetically Modified Drug Forecast by Region (2024-2029)
12.1.2 Global Genetically Modified Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Genetically Modified Drug Forecast by Type
12.7 Global Genetically Modified Drug Forecast by Application
13 Key Players Analysis
13.1 LFB Biotechnologies SA
13.1.1 LFB Biotechnologies SA Company Information
13.1.2 LFB Biotechnologies SA Genetically Modified Drug Product Portfolios and Specifications
13.1.3 LFB Biotechnologies SA Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 LFB Biotechnologies SA Main Business Overview
13.1.5 LFB Biotechnologies SA Latest Developments
13.2 Pharming Group NV
13.2.1 Pharming Group NV Company Information
13.2.2 Pharming Group NV Genetically Modified Drug Product Portfolios and Specifications
13.2.3 Pharming Group NV Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Pharming Group NV Main Business Overview
13.2.5 Pharming Group NV Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Genetically Modified Drug Product Portfolios and Specifications
13.3.3 Pfizer Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Genetically Modified Drug Product Portfolios and Specifications
13.4.3 Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Information
13.5.2 Abbott Laboratories Genetically Modified Drug Product Portfolios and Specifications
13.5.3 Abbott Laboratories Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Abbott Laboratories Main Business Overview
13.5.5 Abbott Laboratories Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Genetically Modified Drug Product Portfolios and Specifications
13.6.3 Johnson & Johnson Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Merck & Co.
13.7.1 Merck & Co. Company Information
13.7.2 Merck & Co. Genetically Modified Drug Product Portfolios and Specifications
13.7.3 Merck & Co. Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Merck & Co. Main Business Overview
13.7.5 Merck & Co. Latest Developments
13.8 Amgen
13.8.1 Amgen Company Information
13.8.2 Amgen Genetically Modified Drug Product Portfolios and Specifications
13.8.3 Amgen Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Amgen Main Business Overview
13.8.5 Amgen Latest Developments
13.9 F. Hoffmann-La Roche
13.9.1 F. Hoffmann-La Roche Company Information
13.9.2 F. Hoffmann-La Roche Genetically Modified Drug Product Portfolios and Specifications
13.9.3 F. Hoffmann-La Roche Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 F. Hoffmann-La Roche Main Business Overview
13.9.5 F. Hoffmann-La Roche Latest Developments
13.10 Sanofi
13.10.1 Sanofi Company Information
13.10.2 Sanofi Genetically Modified Drug Product Portfolios and Specifications
13.10.3 Sanofi Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Sanofi Main Business Overview
13.10.5 Sanofi Latest Developments
13.11 Novartis
13.11.1 Novartis Company Information
13.11.2 Novartis Genetically Modified Drug Product Portfolios and Specifications
13.11.3 Novartis Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Novartis Main Business Overview
13.11.5 Novartis Latest Developments
13.12 Eli Lilly
13.12.1 Eli Lilly Company Information
13.12.2 Eli Lilly Genetically Modified Drug Product Portfolios and Specifications
13.12.3 Eli Lilly Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Eli Lilly Main Business Overview
13.12.5 Eli Lilly Latest Developments
13.13 Takeda
13.13.1 Takeda Company Information
13.13.2 Takeda Genetically Modified Drug Product Portfolios and Specifications
13.13.3 Takeda Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Takeda Main Business Overview
13.13.5 Takeda Latest Developments
13.14 Baxter
13.14.1 Baxter Company Information
13.14.2 Baxter Genetically Modified Drug Product Portfolios and Specifications
13.14.3 Baxter Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Baxter Main Business Overview
13.14.5 Baxter Latest Developments
13.15 GlaxoSmithKline
13.15.1 GlaxoSmithKline Company Information
13.15.2 GlaxoSmithKline Genetically Modified Drug Product Portfolios and Specifications
13.15.3 GlaxoSmithKline Genetically Modified Drug Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 GlaxoSmithKline Main Business Overview
13.15.5 GlaxoSmithKline Latest Developments
14 Research Findings and Conclusion
Table 1. Genetically Modified Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Genetically Modified Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Transgenic Animal
Table 4. Major Players of Transgenic Plant
Table 5. Global Genetically Modified Drug Sales by Type (2018-2023) & (K Units)
Table 6. Global Genetically Modified Drug Sales Market Share by Type (2018-2023)
Table 7. Global Genetically Modified Drug Revenue by Type (2018-2023) & ($ million)
Table 8. Global Genetically Modified Drug Revenue Market Share by Type (2018-2023)
Table 9. Global Genetically Modified Drug Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Genetically Modified Drug Sales by Application (2018-2023) & (K Units)
Table 11. Global Genetically Modified Drug Sales Market Share by Application (2018-2023)
Table 12. Global Genetically Modified Drug Revenue by Application (2018-2023)
Table 13. Global Genetically Modified Drug Revenue Market Share by Application (2018-2023)
Table 14. Global Genetically Modified Drug Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Genetically Modified Drug Sales by Company (2018-2023) & (K Units)
Table 16. Global Genetically Modified Drug Sales Market Share by Company (2018-2023)
Table 17. Global Genetically Modified Drug Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Genetically Modified Drug Revenue Market Share by Company (2018-2023)
Table 19. Global Genetically Modified Drug Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Genetically Modified Drug Producing Area Distribution and Sales Area
Table 21. Players Genetically Modified Drug Products Offered
Table 22. Genetically Modified Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Genetically Modified Drug Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Genetically Modified Drug Sales Market Share Geographic Region (2018-2023)
Table 27. Global Genetically Modified Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Genetically Modified Drug Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Genetically Modified Drug Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Genetically Modified Drug Sales Market Share by Country/Region (2018-2023)
Table 31. Global Genetically Modified Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Genetically Modified Drug Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Genetically Modified Drug Sales by Country (2018-2023) & (K Units)
Table 34. Americas Genetically Modified Drug Sales Market Share by Country (2018-2023)
Table 35. Americas Genetically Modified Drug Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Genetically Modified Drug Revenue Market Share by Country (2018-2023)
Table 37. Americas Genetically Modified Drug Sales by Type (2018-2023) & (K Units)
Table 38. Americas Genetically Modified Drug Sales by Application (2018-2023) & (K Units)
Table 39. APAC Genetically Modified Drug Sales by Region (2018-2023) & (K Units)
Table 40. APAC Genetically Modified Drug Sales Market Share by Region (2018-2023)
Table 41. APAC Genetically Modified Drug Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Genetically Modified Drug Revenue Market Share by Region (2018-2023)
Table 43. APAC Genetically Modified Drug Sales by Type (2018-2023) & (K Units)
Table 44. APAC Genetically Modified Drug Sales by Application (2018-2023) & (K Units)
Table 45. Europe Genetically Modified Drug Sales by Country (2018-2023) & (K Units)
Table 46. Europe Genetically Modified Drug Sales Market Share by Country (2018-2023)
Table 47. Europe Genetically Modified Drug Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Genetically Modified Drug Revenue Market Share by Country (2018-2023)
Table 49. Europe Genetically Modified Drug Sales by Type (2018-2023) & (K Units)
Table 50. Europe Genetically Modified Drug Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Genetically Modified Drug Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Genetically Modified Drug Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Genetically Modified Drug Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Genetically Modified Drug Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Genetically Modified Drug Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Genetically Modified Drug Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Genetically Modified Drug
Table 58. Key Market Challenges & Risks of Genetically Modified Drug
Table 59. Key Industry Trends of Genetically Modified Drug
Table 60. Genetically Modified Drug Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Genetically Modified Drug Distributors List
Table 63. Genetically Modified Drug Customer List
Table 64. Global Genetically Modified Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Genetically Modified Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Genetically Modified Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Genetically Modified Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Genetically Modified Drug Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Genetically Modified Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Genetically Modified Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Genetically Modified Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Genetically Modified Drug Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Genetically Modified Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Genetically Modified Drug Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Genetically Modified Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Genetically Modified Drug Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Genetically Modified Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. LFB Biotechnologies SA Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. LFB Biotechnologies SA Genetically Modified Drug Product Portfolios and Specifications
Table 80. LFB Biotechnologies SA Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. LFB Biotechnologies SA Main Business
Table 82. LFB Biotechnologies SA Latest Developments
Table 83. Pharming Group NV Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. Pharming Group NV Genetically Modified Drug Product Portfolios and Specifications
Table 85. Pharming Group NV Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Pharming Group NV Main Business
Table 87. Pharming Group NV Latest Developments
Table 88. Pfizer Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Genetically Modified Drug Product Portfolios and Specifications
Table 90. Pfizer Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Roche Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Roche Genetically Modified Drug Product Portfolios and Specifications
Table 95. Roche Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Roche Main Business
Table 97. Roche Latest Developments
Table 98. Abbott Laboratories Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Abbott Laboratories Genetically Modified Drug Product Portfolios and Specifications
Table 100. Abbott Laboratories Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Abbott Laboratories Main Business
Table 102. Abbott Laboratories Latest Developments
Table 103. Johnson & Johnson Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Johnson & Johnson Genetically Modified Drug Product Portfolios and Specifications
Table 105. Johnson & Johnson Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Johnson & Johnson Main Business
Table 107. Johnson & Johnson Latest Developments
Table 108. Merck & Co. Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Merck & Co. Genetically Modified Drug Product Portfolios and Specifications
Table 110. Merck & Co. Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Merck & Co. Main Business
Table 112. Merck & Co. Latest Developments
Table 113. Amgen Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Amgen Genetically Modified Drug Product Portfolios and Specifications
Table 115. Amgen Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Amgen Main Business
Table 117. Amgen Latest Developments
Table 118. F. Hoffmann-La Roche Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. F. Hoffmann-La Roche Genetically Modified Drug Product Portfolios and Specifications
Table 120. F. Hoffmann-La Roche Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. F. Hoffmann-La Roche Main Business
Table 122. F. Hoffmann-La Roche Latest Developments
Table 123. Sanofi Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Genetically Modified Drug Product Portfolios and Specifications
Table 125. Sanofi Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
Table 128. Novartis Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. Novartis Genetically Modified Drug Product Portfolios and Specifications
Table 130. Novartis Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Novartis Main Business
Table 132. Novartis Latest Developments
Table 133. Eli Lilly Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Eli Lilly Genetically Modified Drug Product Portfolios and Specifications
Table 135. Eli Lilly Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. Eli Lilly Main Business
Table 137. Eli Lilly Latest Developments
Table 138. Takeda Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. Takeda Genetically Modified Drug Product Portfolios and Specifications
Table 140. Takeda Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Takeda Main Business
Table 142. Takeda Latest Developments
Table 143. Baxter Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 144. Baxter Genetically Modified Drug Product Portfolios and Specifications
Table 145. Baxter Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Baxter Main Business
Table 147. Baxter Latest Developments
Table 148. GlaxoSmithKline Basic Information, Genetically Modified Drug Manufacturing Base, Sales Area and Its Competitors
Table 149. GlaxoSmithKline Genetically Modified Drug Product Portfolios and Specifications
Table 150. GlaxoSmithKline Genetically Modified Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. GlaxoSmithKline Main Business
Table 152. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Picture of Genetically Modified Drug
Figure 2. Genetically Modified Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Genetically Modified Drug Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Genetically Modified Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Genetically Modified Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Transgenic Animal
Figure 10. Product Picture of Transgenic Plant
Figure 11. Global Genetically Modified Drug Sales Market Share by Type in 2022
Figure 12. Global Genetically Modified Drug Revenue Market Share by Type (2018-2023)
Figure 13. Genetically Modified Drug Consumed in Hospital
Figure 14. Global Genetically Modified Drug Market: Hospital (2018-2023) & (K Units)
Figure 15. Genetically Modified Drug Consumed in Clinic
Figure 16. Global Genetically Modified Drug Market: Clinic (2018-2023) & (K Units)
Figure 17. Global Genetically Modified Drug Sales Market Share by Application (2022)
Figure 18. Global Genetically Modified Drug Revenue Market Share by Application in 2022
Figure 19. Genetically Modified Drug Sales Market by Company in 2022 (K Units)
Figure 20. Global Genetically Modified Drug Sales Market Share by Company in 2022
Figure 21. Genetically Modified Drug Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Genetically Modified Drug Revenue Market Share by Company in 2022
Figure 23. Global Genetically Modified Drug Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Genetically Modified Drug Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Genetically Modified Drug Sales 2018-2023 (K Units)
Figure 26. Americas Genetically Modified Drug Revenue 2018-2023 ($ Millions)
Figure 27. APAC Genetically Modified Drug Sales 2018-2023 (K Units)
Figure 28. APAC Genetically Modified Drug Revenue 2018-2023 ($ Millions)
Figure 29. Europe Genetically Modified Drug Sales 2018-2023 (K Units)
Figure 30. Europe Genetically Modified Drug Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Genetically Modified Drug Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Genetically Modified Drug Revenue 2018-2023 ($ Millions)
Figure 33. Americas Genetically Modified Drug Sales Market Share by Country in 2022
Figure 34. Americas Genetically Modified Drug Revenue Market Share by Country in 2022
Figure 35. Americas Genetically Modified Drug Sales Market Share by Type (2018-2023)
Figure 36. Americas Genetically Modified Drug Sales Market Share by Application (2018-2023)
Figure 37. United States Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Genetically Modified Drug Sales Market Share by Region in 2022
Figure 42. APAC Genetically Modified Drug Revenue Market Share by Regions in 2022
Figure 43. APAC Genetically Modified Drug Sales Market Share by Type (2018-2023)
Figure 44. APAC Genetically Modified Drug Sales Market Share by Application (2018-2023)
Figure 45. China Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Genetically Modified Drug Sales Market Share by Country in 2022
Figure 53. Europe Genetically Modified Drug Revenue Market Share by Country in 2022
Figure 54. Europe Genetically Modified Drug Sales Market Share by Type (2018-2023)
Figure 55. Europe Genetically Modified Drug Sales Market Share by Application (2018-2023)
Figure 56. Germany Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Genetically Modified Drug Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Genetically Modified Drug Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Genetically Modified Drug Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Genetically Modified Drug Sales Market Share by Application (2018-2023)
Figure 65. Egypt Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Genetically Modified Drug Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Genetically Modified Drug in 2022
Figure 71. Manufacturing Process Analysis of Genetically Modified Drug
Figure 72. Industry Chain Structure of Genetically Modified Drug
Figure 73. Channels of Distribution
Figure 74. Global Genetically Modified Drug Sales Market Forecast by Region (2024-2029)
Figure 75. Global Genetically Modified Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Genetically Modified Drug Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Genetically Modified Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Genetically Modified Drug Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Genetically Modified Drug Revenue Market Share Forecast by Application (2024-2029)
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
